Reimagining Weight Management with Digital Opinion Leaders, held between 27–28 January in Dubai. As the first summit of its ...

The healthcare sector lagged broader equities last year. Novo Nordisk ( NVO 2.86%) and Merck ( MRK 0.62%), two pharmaceutical ...

Effective prevention and management of type 2 diabetes mellitus (T2DM) can improve patient outcomes and reduce health care-related environmental impact.

Denmark has begun a government analysis of small modular reactors to explore their role in energy security, safety, and regulatory prospects.

Danish national registry data suggest adults with type 2 diabetes taking SGLT2 inhibitors have a slightly lower risk of developing diabetic foot problems than those taking GLP-1 receptor agonists.

Novo Nordisk A/S Q3 costs, Q4 savings, and oral Wegovy launch drive EPS upside. Click for this NVO stock update and earnings preview.

However, not everyone is willing—or able—to indefinitely commit to GLP-1s.

Florida State University is looking to participate in what could be a groundbreaking drug discovery study through a ...

A framework is now in place for investigating the "potential and risks" of new nuclear technologies - including small modular reactors - and the lifting of a moratorium on nuclear power, Denmark's ...

The nation’s largest nonprofit remains tightly linked to a fast-growing technology company at the center of the AI boom.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...

The findings shed new light on human reproduction and suggest pathways for developing treatments to lower the risk of ...